Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease

NCT07417696 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

NETWORK

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Palmitoleic Acid + Infliximab
DRUG: Infliximab

Sponsor

Chinese Medical Association

Collaborators

[object Object]
[object Object]
[object Object]